Related Experiment Video
Updated: Feb 13, 2026

Author Spotlight: Decoding Corneal Neovascularization with Alkali Burn Model for Future Therapeutic Strategies
Published on: June 30, 2023
Transcriptome Profiling of Neovascularized Corneas Reveals miR-204 as a Multi-target Biotherapy Deliverable by rAAVs
Yi Lu1, Phillip W L Tai2, Jianzhong Ai3
1Department of Ophthalmology, Shanghai General Hospital, Shanghai Jiaotong University, Shanghai 200080, China; Shanghai Key Laboratory of Ocular Fundus Diseases, Shanghai 200080, China; Shanghai Engineering Center for Visual Science and Photomedicine, Shanghai 200080, China; Horae Gene Therapy Center, UMass Medical School, Worcester, MA 01605, USA.
Researchers discovered miR-204, a microRNA (miRNA), that can treat corneal neovascularization (NV). Delivered via gene therapy using recombinant adeno-associated viruses (rAAVs), this approach offers a safe and effective alternative for reducing blood vessel growth in the eye.
Area of Science:
- Ophthalmology
- Molecular Biology
- Gene Therapy
Background:
- Corneal neovascularization (NV) is a significant cause of vision loss driven by angiogenic factors.
- Existing treatments for corneal NV have limitations, including frequent administration and variable efficacy.
Purpose of the Study:
- To identify novel anti-angiogenic microRNAs (miRNAs) for treating corneal neovascularization.
- To develop a gene therapy framework using recombinant adeno-associated viruses (rAAVs) for miRNA delivery.
Main Methods:
- Differential expression analysis of miRNAs in alkali burn-induced mouse corneal neovascularization.
- Bioinformatic prediction of miRNA targets among differentially expressed corneal mRNAs.
- In vivo assessment of miR-204 delivery via rAAV in a mouse model of corneal NV.
Main Results:
- Identified 39 differentially expressed miRNAs predicted to target over 5,500 mRNAs.
- Demonstrated that rAAV-mediated delivery of miR-204 effectively reduced corneal vascularization in mice.
- Showcased normalization of target genes and biological pathways by miR-204, attenuating neovascularization.
Conclusions:
- miR-204 is a promising therapeutic miRNA for mitigating corneal neovascularization.
- rAAV-based delivery of miR-204 represents a safe and efficacious gene therapy strategy for corneal disorders.
- This study provides a framework for discovering and translating miRNAs into viable biotherapies for ocular diseases.
Related Concept Videos
Multi-input and Multi-variable systems
In the absence of...
Ribosome Profiling
Applications of ribosome profiling
Ribosome profiling has many applications, including in vivo monitoring of translation inside a particular organ or tissue type and quantifying new protein synthesis levels.
The technique...
Multi-Step Reactions
Taping Over Different Ground Profiles
Multi-species Conserved Sequences
Although the genome of each species varies greatly from each other, a few sequences are highly conserved. Such conserved...
Profile Leveling and Cross Sections

